Departments of Pediatrics and Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Int J Obes (Lond). 2022 Apr;46(4):843-850. doi: 10.1038/s41366-021-01023-w. Epub 2022 Jan 8.
Prior studies of early antibiotic use and growth have shown mixed results, primarily on cross-sectional outcomes. This study examined the effect of oral antibiotics before age 24 months on growth trajectory at age 2-5 years.
We captured oral antibiotic prescriptions and anthropometrics from electronic health records through PCORnet, for children with ≥1 height and weight at 0-12 months of age, ≥1 at 12-30 months, and ≥2 between 25 and 72 months. Prescriptions were grouped into episodes by time and by antimicrobial spectrum. Longitudinal rate regression was used to assess differences in growth rate from 25 to 72 months of age. Models were adjusted for sex, race/ethnicity, steroid use, diagnosed asthma, complex chronic conditions, and infections.
430,376 children from 29 health U.S. systems were included, with 58% receiving antibiotics before 24 months. Exposure to any antibiotic was associated with an average 0.7% (95% CI 0.5, 0.9, p < 0.0001) greater rate of weight gain, corresponding to 0.05 kg additional weight. The estimated effect was slightly greater for narrow-spectrum (0.8% [0.6, 1.1]) than broad-spectrum (0.6% [0.3, 0.8], p < 0.0001) drugs. There was a small dose response relationship between the number of antibiotic episodes and weight gain.
Oral antibiotic use prior to 24 months of age was associated with very small changes in average growth rate at ages 2-5 years. The small effect size is unlikely to affect individual prescribing decisions, though it may reflect a biologic effect that can combine with others.
先前关于早期使用抗生素和生长的研究结果喜忧参半,主要是基于横断面研究结果。本研究旨在探讨 24 个月龄前口服抗生素对 2-5 岁生长轨迹的影响。
我们通过 PCORnet 从电子健康记录中捕获口服抗生素处方和人体测量数据,纳入 0-12 个月至少有 1 次身高和体重测量值、12-30 个月至少有 1 次身高和体重测量值、25-72 个月至少有 2 次身高和体重测量值的儿童。通过时间和抗菌谱将处方分组为疗程。使用纵向速率回归评估 25-72 个月期间的生长速度差异。模型调整了性别、种族/族裔、类固醇使用、诊断性哮喘、复杂慢性疾病和感染等因素。
来自 29 个美国医疗系统的 430376 名儿童被纳入研究,其中 58%的儿童在 24 个月龄前接受过抗生素治疗。使用任何抗生素与体重增加率平均增加 0.7%(95%CI 0.5,0.9,p<0.0001)相关,体重增加 0.05kg。与广谱抗生素(0.6%[0.3,0.8])相比,窄谱抗生素(0.8%[0.6,1.1])的估计效果略大(p<0.0001)。抗生素疗程数与体重增加之间存在较小的剂量反应关系。
24 个月龄前使用口服抗生素与 2-5 岁时平均生长速度的微小变化相关。这种小的效应量不太可能影响个体的处方决策,尽管它可能反映了一种可能与其他因素结合的生物学效应。